Hygetropin biz (Hygetropin) 10 fl x 10 ME

Hygetropin / Hygetropin – human growth hormone of the recombinant group. It contains a standard set of amino acids. Hygetropin is similar to growth hormone produced naturally in the body. The active substance in Hygetropin is somatropin. It is used to accelerate growth in childhood, during surgical interventions, as an accelerator of healing of serious wounds and complex extensive burns. It is used by adults to achieve excellent results in the formation of a beautiful body. Hygetropin is produced by the Chinese corporation Zhongshan Hygene Biopharm Co., which has a certified GMP production and a narrow specialization: the production of only recombinant human growth hormone (rHGH). It is also SFDA certified and therefore has the right to supply growth hormone for the domestic market of China. Hygetropin is produced in a dosage of 8 units. and 10 units Ampoules with the growth hormone Hygetropin are sealed with vacuum and the addition of inert gas for better preservation of somatropin. One of the indirect signs of the originality of Hygetropin can be the high degree of rarefaction in the bottle, thanks to which it is enough to insert the needle through the stopper and the liquid begins to be drawn in independently from the syringe with water for injection.

In addition, Hygetropin promotes:

• Reduction of fatty deposits;
• Improving vision and memory;
• Increasing immunity;
• Reduction of wrinkles and good skin condition;
• Increasing the growth of muscle mass;
• Increasing libido and sexual activity;
• Restoration of natural hair color.

PHARMACOLOGICAL PROPERTIES:

recombinant human growth hormone. It is a peptide of 191 amino acids, identical to human pituitary growth hormone in amino acid sequence and composition, as well as in peptide map, isoelectric point, molecular mass, isomeric structure and biological activity.
It has anabolic and anti-catabolic effects, affects metabolism, growth and development of the body. It interacts with specific receptors of cells of different types, including myocytes, hepatocytes, adipocytes, lymphocytes and hematopoietic cells. Some ego effects are mediated by the second class of hormones — somatomedins (IGF1 and IGF2).
Depending on the dose, somatropin causes an increase in the level of IGF1, IGFBP3, non-esterified fatty acids and glycerol, a decrease in the level of urea in the blood and nitrogen in the urine, and a decrease in the excretion of sodium and potassium. When used in high doses, relative saturation of the effects of somatropin is possible. This does not apply to glycemia and urinary excretion of C-peptide, which significantly increase only after high doses (20 mg). In higher doses (60 IU, or 20 mg), it is impossible to exclude some degree of nonlinearity, which, however, does not have clinical significance. After intravenous administration to healthy volunteers, the volume of distribution in the steady state is almost 7 l, the total clearance — 15 l/h, while renal clearance is insignificant. T½— 20–35 min.
After a single subcutaneous and intravenous injection of terminal T½ several more — 2– 4 h. The concentration of growth hormone in the blood reaches a maximum after approximately 4 hours and returns to the initial level within 24 hours, which indicates the absence of accumulation of growth hormone during repeated administrations. Bioavailability with both routes of administration is 70–90%.

See other гормоны роста